The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of glembatumumab vedotin (GV), an antibody-drug conjugate (ADC) targeting gpNMB, in advanced melanoma.
 
Patrick Alexander Ott
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Genentech; Neon Therapeutics
Research Funding - ARMO BioSciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst)
 
Anna C. Pavlick
Honoraria - Bristol-Myers Squibb; Merck; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis
 
Douglas Buckner Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Genoptix
Research Funding - Incyte
 
Lowell L. Hart
Speakers' Bureau - Genentech; Novartis
Research Funding - Genentech; Novartis
 
Jeffrey R. Infante
Research Funding - Aileron Therapeutics (Inst); ARMO BioSciences (Inst); AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Celldex (Inst); Celldex (Inst); eFFECTOR Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Janssen Oncology (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Phosplatin Therapeutics (Inst); Roche (Inst); Roche (Inst); Tesaro (Inst)
 
Jason John Luke
Honoraria - Intellisphere, LLC
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca/MedImmune; Benevir; Bristol-Myers Squibb; Checkmate Pharmaceuticals; EMD Serono; Merck; Novartis
Research Funding - Abbvie; Boston Biomedical; Bristol-Myers Squibb; Celldex; Corvus Pharmaceuticals; Delcath Systems; Five Prime Therapeutics; Genentech/Roche; Immunocore; Incyte; MedImmune; Merck; Pharmacyclics
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Jose Lutzky
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Novartis
Research Funding - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Elios Pharmaceutical; Genentech/Roche; Incyte; Merck; Merck Serono; Novartis; Pfizer; Viralytics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Neal Evan Rothschild
No Relationships to Disclose
 
Lynn E. Spitler
No Relationships to Disclose
 
Charles Lance Cowey
Honoraria - Bristol-Myers Squibb; Genentech; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Genentech; Novartis
Research Funding - Array BioPharma; Bristol-Myers Squibb; Celldex; Genentech; Merck; Novartis
 
Aaron Alizadeh
No Relationships to Disclose
 
April K. Salama
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Abbvie (I); Bristol-Myers Squibb (Inst); Celldex (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Merck (Inst); Reata Pharmaceuticals (Inst)
 
Xiaoyan Yin
Employment - Celldex
Stock and Other Ownership Interests - Celldex
 
Rebecca G. Bagley
Employment - Celldex
Stock and Other Ownership Interests - Celldex
 
Ying Wang
Employment - Celldex
Stock and Other Ownership Interests - Celldex
 
Omid Hamid
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Genentech (Inst); Immunocore (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Rinat (Inst); Roche (Inst)